Uncertainty regarding ezetimibe and cancer risk The road less travelledAdministering drugs by nonapproved routes. Practice Issues: Eye on Technology - The medication-use cycle Systems and technologies that can be used to reduce error rates in prescription and transcription stages. Practice Issues: Adverse Reactions - ESAs for cancer-related anemia Trials assess ESA use for the treatment of anemia among patients with cancer. Editorial: Blue skies ahead Blueprint for Pharmacy a chance to collectively move the profession forward. Chronic disease management report highlights collaboration Saskatchewan project largest of its kind in Canada. Practice Issues: Adverse Reactions - SSRIs and bleeding risk Two papers investigate effects of SSRIs and bleeding risk. Drug News: July/August 2008 Stalevo: new combo for Parkinson’s disease; Vectibix for colorectal cancer. The pharmacy landscape What’s changed and what hasn’t? TB: A global burden Tuberculosis, a formidable disease that affects more than one-third of the world’s population. First Previous 2370 2371 2372 2373 2374 Next Last
